A systematic review of the Huntington Disease-Like 2 Phenotype

David G. Anderson, Ruth H. Walker, Myles Connor, Jonathan Carr, Russell Louis Margolis, Amanda Krause

Research output: Contribution to journalArticle

Abstract

Background: Huntington Disease-like 2 (HDL2) is a neurodegenerative disorder similar to Huntington Disease (HD) in its clinical phenotype, genetic characteristics, neuropathology and longitudinal progression. Proposed specific differences include an exclusive African ancestry, lack of eye movement abnormalities, increased Parkinsonism, and acanthocytes in HDL2. Objective: The objective was to determine the similarities and differences between HD and HDL2 by establishing the clinical phenotype of HDL2 with the published cases. Methods: A literature review of all clinically described cases of HDL2 until the end of 2016 was performed and a descriptive analysis was carried out. Results: Sixty-nine new cases were described between 2001 and 2016. All cases had likely African ancestry, and most were found in South Africa and the USA. Many features were found to be similar to HD, including a strong negative correlation between repeat length and age of onset. Chorea was noted in 48/57 cases (84%). Dementia was reported in 74% patients, and Parkinsonism in 37%. Psychiatric features were reported in 44 out of 47 cases. Patients with chorea had lower expanded repeat lengths compared to patients without chorea. Eye movements were described in 19 cases, 8 were abnormal. Acanthocytes were detected in 4 of the 13 patients tested. Nineteen out of 20 MRIs were reported as abnormal with findings similar to HD. Conclusion: This review clarifies some aspects of the HDL2 phenotype and highlights others which require further investigation. Features that are unique to HDL2 have been documented in a minority of subjects and require prospective validation.

Original languageEnglish (US)
Pages (from-to)37-46
Number of pages10
JournalJournal of Huntington's disease
Volume6
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Phenotype
Huntington Disease
Chorea
Acanthocytes
Parkinsonian Disorders
Eye Movements
Eye Abnormalities
South Africa
Huntington Disease-Like 2
Age of Onset
Neurodegenerative Diseases
Psychiatry
Dementia

Keywords

  • Acanthocytosis
  • chorea
  • HDL2
  • Huntington disease-like 2
  • Huntington's disease
  • junctophilin-3

ASJC Scopus subject areas

  • Medicine(all)
  • Clinical Neurology
  • Cellular and Molecular Neuroscience

Cite this

A systematic review of the Huntington Disease-Like 2 Phenotype. / Anderson, David G.; Walker, Ruth H.; Connor, Myles; Carr, Jonathan; Margolis, Russell Louis; Krause, Amanda.

In: Journal of Huntington's disease, Vol. 6, No. 1, 2017, p. 37-46.

Research output: Contribution to journalArticle

Anderson, DG, Walker, RH, Connor, M, Carr, J, Margolis, RL & Krause, A 2017, 'A systematic review of the Huntington Disease-Like 2 Phenotype', Journal of Huntington's disease, vol. 6, no. 1, pp. 37-46. https://doi.org/10.3233/JHD-160232
Anderson, David G. ; Walker, Ruth H. ; Connor, Myles ; Carr, Jonathan ; Margolis, Russell Louis ; Krause, Amanda. / A systematic review of the Huntington Disease-Like 2 Phenotype. In: Journal of Huntington's disease. 2017 ; Vol. 6, No. 1. pp. 37-46.
@article{6fef207e945f4b65b395207f56789a80,
title = "A systematic review of the Huntington Disease-Like 2 Phenotype",
abstract = "Background: Huntington Disease-like 2 (HDL2) is a neurodegenerative disorder similar to Huntington Disease (HD) in its clinical phenotype, genetic characteristics, neuropathology and longitudinal progression. Proposed specific differences include an exclusive African ancestry, lack of eye movement abnormalities, increased Parkinsonism, and acanthocytes in HDL2. Objective: The objective was to determine the similarities and differences between HD and HDL2 by establishing the clinical phenotype of HDL2 with the published cases. Methods: A literature review of all clinically described cases of HDL2 until the end of 2016 was performed and a descriptive analysis was carried out. Results: Sixty-nine new cases were described between 2001 and 2016. All cases had likely African ancestry, and most were found in South Africa and the USA. Many features were found to be similar to HD, including a strong negative correlation between repeat length and age of onset. Chorea was noted in 48/57 cases (84{\%}). Dementia was reported in 74{\%} patients, and Parkinsonism in 37{\%}. Psychiatric features were reported in 44 out of 47 cases. Patients with chorea had lower expanded repeat lengths compared to patients without chorea. Eye movements were described in 19 cases, 8 were abnormal. Acanthocytes were detected in 4 of the 13 patients tested. Nineteen out of 20 MRIs were reported as abnormal with findings similar to HD. Conclusion: This review clarifies some aspects of the HDL2 phenotype and highlights others which require further investigation. Features that are unique to HDL2 have been documented in a minority of subjects and require prospective validation.",
keywords = "Acanthocytosis, chorea, HDL2, Huntington disease-like 2, Huntington's disease, junctophilin-3",
author = "Anderson, {David G.} and Walker, {Ruth H.} and Myles Connor and Jonathan Carr and Margolis, {Russell Louis} and Amanda Krause",
year = "2017",
doi = "10.3233/JHD-160232",
language = "English (US)",
volume = "6",
pages = "37--46",
journal = "Journal of Huntington's disease",
issn = "1879-6397",
publisher = "IOS Press",
number = "1",

}

TY - JOUR

T1 - A systematic review of the Huntington Disease-Like 2 Phenotype

AU - Anderson, David G.

AU - Walker, Ruth H.

AU - Connor, Myles

AU - Carr, Jonathan

AU - Margolis, Russell Louis

AU - Krause, Amanda

PY - 2017

Y1 - 2017

N2 - Background: Huntington Disease-like 2 (HDL2) is a neurodegenerative disorder similar to Huntington Disease (HD) in its clinical phenotype, genetic characteristics, neuropathology and longitudinal progression. Proposed specific differences include an exclusive African ancestry, lack of eye movement abnormalities, increased Parkinsonism, and acanthocytes in HDL2. Objective: The objective was to determine the similarities and differences between HD and HDL2 by establishing the clinical phenotype of HDL2 with the published cases. Methods: A literature review of all clinically described cases of HDL2 until the end of 2016 was performed and a descriptive analysis was carried out. Results: Sixty-nine new cases were described between 2001 and 2016. All cases had likely African ancestry, and most were found in South Africa and the USA. Many features were found to be similar to HD, including a strong negative correlation between repeat length and age of onset. Chorea was noted in 48/57 cases (84%). Dementia was reported in 74% patients, and Parkinsonism in 37%. Psychiatric features were reported in 44 out of 47 cases. Patients with chorea had lower expanded repeat lengths compared to patients without chorea. Eye movements were described in 19 cases, 8 were abnormal. Acanthocytes were detected in 4 of the 13 patients tested. Nineteen out of 20 MRIs were reported as abnormal with findings similar to HD. Conclusion: This review clarifies some aspects of the HDL2 phenotype and highlights others which require further investigation. Features that are unique to HDL2 have been documented in a minority of subjects and require prospective validation.

AB - Background: Huntington Disease-like 2 (HDL2) is a neurodegenerative disorder similar to Huntington Disease (HD) in its clinical phenotype, genetic characteristics, neuropathology and longitudinal progression. Proposed specific differences include an exclusive African ancestry, lack of eye movement abnormalities, increased Parkinsonism, and acanthocytes in HDL2. Objective: The objective was to determine the similarities and differences between HD and HDL2 by establishing the clinical phenotype of HDL2 with the published cases. Methods: A literature review of all clinically described cases of HDL2 until the end of 2016 was performed and a descriptive analysis was carried out. Results: Sixty-nine new cases were described between 2001 and 2016. All cases had likely African ancestry, and most were found in South Africa and the USA. Many features were found to be similar to HD, including a strong negative correlation between repeat length and age of onset. Chorea was noted in 48/57 cases (84%). Dementia was reported in 74% patients, and Parkinsonism in 37%. Psychiatric features were reported in 44 out of 47 cases. Patients with chorea had lower expanded repeat lengths compared to patients without chorea. Eye movements were described in 19 cases, 8 were abnormal. Acanthocytes were detected in 4 of the 13 patients tested. Nineteen out of 20 MRIs were reported as abnormal with findings similar to HD. Conclusion: This review clarifies some aspects of the HDL2 phenotype and highlights others which require further investigation. Features that are unique to HDL2 have been documented in a minority of subjects and require prospective validation.

KW - Acanthocytosis

KW - chorea

KW - HDL2

KW - Huntington disease-like 2

KW - Huntington's disease

KW - junctophilin-3

UR - http://www.scopus.com/inward/record.url?scp=85016505445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85016505445&partnerID=8YFLogxK

U2 - 10.3233/JHD-160232

DO - 10.3233/JHD-160232

M3 - Article

VL - 6

SP - 37

EP - 46

JO - Journal of Huntington's disease

JF - Journal of Huntington's disease

SN - 1879-6397

IS - 1

ER -